Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.610
-0.050 (-3.01%)
Oct 3, 2025, 4:00 PM EDT - Market closed
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $116.14 million as of October 3, 2025. Its market cap has decreased by -60.74% in one year.
Market Cap
116.14M
Enterprise Value
-145.98M
1-Year Change
-60.74%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $116.14M, a decrease of -80.23%. That is a compound annual growth rate of -25.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 116.14M | -46.22% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 259.09% |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |